S
Shanghai ERP peptide Biotechnology
Request Full Data Access to the PeptideMeter database of peptide tests.
Products
| Product | Rating | Count | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | C | 12 | 6.5 | 4.8 | 8.0 | 11 Dec 2025 |
| HGH | X | 1 | 9.5 | 9.5 | 9.5 | 25 May 2026 |
| 17a-Methyl-1-Testosterone | X | 1 | 8.4 | 8.4 | 8.4 | 16 Mar 2025 |
| AICAR | X | 1 | 9.4 | 9.4 | 9.4 | 24 Apr 2025 |
| Anastrozole (Arimidex) Raw | X | 1 | 6.8 | 6.8 | 6.8 | 7 May 2025 |
| Andarine S4 | X | 1 | 5.7 | 5.7 | 5.7 | 6 May 2025 |
| Aromasin (Exemestane) | X | 1 | 6.9 | 6.9 | 6.9 | 16 Mar 2025 |
| BAC Water | X | 1 | 6.3 | 6.3 | 6.3 | 13 Jun 2025 |
| Botulinum toxin | X | 1 | 8.0 | 8.0 | 8.0 | 8 Jul 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X | 1 | 6.3 | 6.3 | 6.3 | 3 Jun 2025 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | X | 1 | 5.9 | 5.9 | 5.9 | 6 May 2025 |
| Dapoxetine | X | 1 | 6.5 | 6.5 | 6.5 | 28 Mar 2025 |
| DSIP | X | 1 | 4.5 | 4.5 | 4.5 | 17 Dec 2024 |
| GHRP-6 Acetate | X | 1 | 7.6 | 7.6 | 7.6 | 2 Jul 2025 |
| KissPeptin-10 | X | 1 | 7.3 | 7.3 | 7.3 | 21 May 2025 |
| KPV Oral | X | 1 | 4.6 | 4.6 | 4.6 | 6 May 2025 |
| LGD-4033 (Ligandrol) Raw | X | 1 | 7.9 | 7.9 | 7.9 | 25 Apr 2025 |
| Lipo-C 120mg | X | 1 | 6.1 | 6.1 | 6.1 | 17 Dec 2024 |
| MOTS-C | X | 1 | 5.0 | 5.0 | 5.0 | 3 Jun 2025 |
| MT-1 | X | 1 | 8.9 | 8.9 | 8.9 | 8 Jul 2025 |
| Nandrolone Phenylpropionate (NPP) Raw | X | 1 | 7.5 | 7.5 | 7.5 | 25 Apr 2025 |
| NandroMix 300 | X | 1 | 6.9 | 6.9 | 6.9 | 11 Jun 2025 |
| Orforglipron | X | 1 | 4.4 | 4.4 | 4.4 | 11 Jun 2025 |
| Pinealon | X | 1 | 8.1 | 8.1 | 8.1 | 2 Apr 2025 |
| Primobolan Oral (Methenolone Acetate) | X | 1 | 4.8 | 4.8 | 4.8 | 20 Jun 2025 |
| RAD-140 (Testolone) Raw | X | 1 | 6.5 | 6.5 | 6.5 | 25 Apr 2025 |
| Retatrutide 30mg Pen Kit | X | 1 | 4.1 | 4.1 | 4.1 | 11 Jun 2025 |
| Retatrutide 5mg + Cagrilintide 5mg Blend | X | 1 | 7.7 | 7.7 | 7.7 | 3 Jul 2025 |
| Semaglutide Raw | X | 1 | 6.9 | 6.9 | 6.9 | 28 Mar 2025 |
| SR9009 | X | 1 | 4.0 | 3.5 | 3.5 | 27 Feb 2025 |
| SS-31 (Elamipretide) Raw | X | 1 | 6.0 | 6.0 | 6.0 | 14 Jan 2025 |
| Telmisartan | X | 1 | 8.9 | 8.9 | 8.9 | 6 May 2025 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | X | 1 | 5.9 | 5.9 | 5.9 | 6 May 2025 |
| Test Propionate | X | 1 | 6.8 | 6.8 | 6.8 | 6 May 2025 |
| Vesugen | X | 1 | 6.2 | 6.2 | 6.2 | 25 Apr 2025 |
| Vilon | X | 1 | 6.9 | 6.9 | 6.9 | 27 Feb 2025 |
Test Results
| Date | Product | Score | Expected | Actual | Deviation | Purity | Lab |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | Retatrutide 5mg + Cagrilintide 5mg Blend | 7.2 | 2mg | 2.0mg | +0.2% | 98.03% | Lab D |
| 24 May 2026 | Telmisartan | 9.0 | 100mg | 93.0mg | -7.0% | 96.23% | Lab C |
| 24 May 2026 | Retatrutide | 5.2 | 12mg | (no batch claim) | 12.4mg | +3.3% | No Label / Silver Crimp / Purple Cap |
| 24 May 2026 | GHRP-6 Acetate | 7.1 | 2mg | 2.5mg | +24.7% | 98.22% | Lab D |
| 24 May 2026 | Vilon | 6.4 | 15mg | 13.6mg | -9.2% | 97.49% | Lab F |
| 24 May 2026 | Anastrozole (Arimidex) Raw | 6.5 | 5g | 4.7g | -6.4% | 96.41% | Lab D |
| 24 May 2026 | BAC Water | 7.0 | 20mg | 19.1mg | -4.7% | 98.25% | Lab G |
| 24 May 2026 | Dapoxetine | 7.0 | 10mg | 12.1mg | +20.8% | 96.93% | Lab A |
| 23 May 2026 | DSIP | 5.3 | 50mg | 47.4mg | -5.1% | 96.50% | Lab C |
| 23 May 2026 | Primobolan Oral (Methenolone Acetate) | 4.6 | 10mg | 9.5mg | -5.3% | 98.99% | Lab F |
| 23 May 2026 | Retatrutide 30mg Pen Kit | 4.0 | 2mg | 2.1mg | +3.1% | 98.50% | Lab C |
| 21 May 2026 | Retatrutide | 5.4 | 10mg | (no batch claim) | 8.33mg | -16.7% | (no data) |
| 21 May 2026 | Retatrutide | 7.5 | 20mg | (no batch claim) | 23.1mg | +15.5% | No Label / Silver Crimp / Blue Cap |
| 21 May 2026 | Retatrutide | 4.8 | 30mg | (no batch claim) | 19.2mg | -36.0% | No Label / Silver Crimp / Violet Cap |
| 20 May 2026 | RAD-140 (Testolone) Raw | 8.4 | 1g | 1.0g | +1.2% | 99.73% | Lab G |
| 19 May 2026 | Orforglipron | 4.0 | 50mg | 44.7mg | -10.7% | 95.04% | Lab F |
| 17 May 2026 | MT-1 | 9.8 | 50mg | 52.8mg | +5.6% | 99.13% | Lab E |
| 26 Jan 2026 | Retatrutide | 6.3 | 10mg | (no batch claim) | 11mg | +10.0% | No Label / Silver Crimp / White Cap |
| 19 Jan 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 6.6 | 50mg | 43.2mg | -13.6% | 95.54% | Lab G |
| 19 Jan 2026 | SR9009 | 4.0 | 20mg | 18.1mg | -9.3% | 99.76% | Lab A |
| 19 Jan 2026 | SS-31 (Elamipretide) Raw | 4.3 | 5g | 5.4g | +9.0% | 99.08% | Lab C |
| 9 Jan 2026 | Nandrolone Phenylpropionate (NPP) Raw | 7.5 | 5g | 5.5g | +9.6% | 96.76% | Lab F |
| 9 Jan 2026 | Test Propionate | 7.7 | 250mg/ml | 286.1mg/ml | +14.5% | 99.11% | Lab E |
| 7 Jan 2026 | KPV Oral | 4.4 | 100mg | 100.4mg | +0.4% | 99.80% | Lab A |
| 1 Jan 2026 | Retatrutide | 7.4 | 20mg | 23.9mgpackage | 21.4mg | -10.3% | No Label / Silver Crimp / Blue Cap |
| 29 Dec 2025 | Retatrutide | 8.0 | 12mg | (no batch claim) | 12mg | No Label / Silver Crimp / Purple Cap | |
| 29 Dec 2025 | KissPeptin-10 | 8.6 | 5mg | 4.7mg | -5.8% | 96.34% | Lab C |
| 29 Dec 2025 | Vesugen | 8.9 | 10mg | 12.0mg | +19.6% | 96.38% | Lab C |
| 12 Dec 2025 | AICAR | 9.1 | 30mg | 29.4mg | -2.2% | 96.70% | Lab B |
| 12 Dec 2025 | Andarine S4 | 6.6 | 10mg | 10.0mg | +0.1% | 99.03% | Lab E |
| 5 Dec 2025 | Aromasin (Exemestane) | 6.9 | 50mg | 48.4mg | -3.2% | 98.16% | Lab A |
| 23 Nov 2025 | 17a-Methyl-1-Testosterone | 9.1 | 50mg | 52.3mg | +4.5% | 96.56% | Lab B |
| 17 Nov 2025 | Lipo-C 120mg | 6.0 | 300mg/ml | 369.0mg/ml | +23.0% | 97.21% | Lab D |
| 17 Nov 2025 | Pinealon | 7.5 | 20mg | 22.1mg | +10.4% | 95.95% | Lab A |
| 14 Nov 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.7 | 10mg | 8.7mg | -12.6% | 98.05% | Lab G |
| 14 Nov 2025 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 4.0 | 30mg | 28.2mg | -6.1% | 99.29% | Lab C |
| 5 Nov 2025 | Botulinum toxin | 7.2 | 30mg | 29.2mg | -2.6% | 96.32% | Lab C |
| 5 Nov 2025 | NandroMix 300 | 6.7 | 300mg/ml | 282.9mg/ml | -5.7% | 97.90% | Lab G |
| 4 Nov 2025 | LGD-4033 (Ligandrol) Raw | 7.2 | 100g | 97.9g | -2.1% | 95.09% | Lab A |
| 17 Oct 2025 | Semaglutide Raw | 8.1 | 100g | 120.9g | +20.9% | 96.50% | Lab G |
| 9 Oct 2025 | MOTS-C | 4.2 | 2mg | 2.0mg | +1.6% | 96.47% | Lab D |